J.B. Chemicals & Pharmaceuticals (BOM:506943) YoY EBITDA Growth : 11.05% (As of Sep. 2024)

View and export this data going back to 1991. Start your Free Trial

What is J.B. Chemicals & Pharmaceuticals YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. J.B. Chemicals & Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 11.05%.

J.B. Chemicals & Pharmaceuticals's EBITDA per Share for the three months ended in Sep. 2024 was ₹17.67.

J.B. Chemicals & Pharmaceuticals YoY EBITDA Growth Historical Data

The historical data trend for J.B. Chemicals & Pharmaceuticals's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.B. Chemicals & Pharmaceuticals YoY EBITDA Growth Chart

J.B. Chemicals & Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

24.50

65.57

-13.43

139.04

-34.62

J.B. Chemicals & Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EBITDA Growth	Get a 7-Day Free Trial															33.35	28.21	22.63	19.24	11.05

J.B. Chemicals & Pharmaceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

J.B. Chemicals & Pharmaceuticals's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(58.862	-	90.034)	/	\| 90.034 \|
=	-34.62 %

J.B. Chemicals & Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2024 )
=	(EBITDA per Share (Q: Sep. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(17.673	-	15.914)	/	\| 15.914 \|
=	11.05 %

J.B. Chemicals & Pharmaceuticals YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of J.B. Chemicals & Pharmaceuticals's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

J.B. Chemicals & Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.B. Chemicals & Pharmaceuticals Ltd (BOM:506943) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

JBCHEPHARM:India

Address

Appa Saheb Marathe Marg, Cnergy IT Park, Unit A2, 3rd floor, Unit A, 8th floor, Prabhadevi, Mumbai, MH, IND, 400 025

Website

https://www.jbpharma.com

J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, injectable, creams, ointments, lozenges, herbal liquids, and capsules. It also offers services including optimization of formulations, scale-up services, stability testing, regulatory support, packaging design, and commercial production. The group derives revenue from the manufacturing and marketing of a diverse range of pharmaceutical products. The company sells its products in India and also exports them to other international countries.

J.B. Chemicals & Pharmaceuticals Headlines

No Headlines